DCM
BIVV

Delpha Capital Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Delpha Capital Management’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-797
Closed -$43K – 1675
2017
Q4 		$43K Buy
+797
New +$43.6K 0.05% 382

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Delpha Capital Management's BIVV Position: Q1 2018 in Review

Delpha Capital Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 797 shares — an estimated $43K sold.

Delpha Capital Management first reported a position in BIVV in Q4 2017 and held it in 1 quarter. The position peaked at $43K in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Delpha Capital Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Delpha Capital Management sold 797 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $43K.
  • Delpha Capital Management first reported a position in Bioverativ Inc. Common Stock in Q4 2017 and held it in 1 quarter.
  • Delpha Capital Management's Bioverativ Inc. Common Stock position peaked at $43K in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Delpha Capital Management's 13F filing for Q1 2018, filed 11 May 2018.